so what I’m saying in short:
Sarepta have 2 drugs for DMD and approved by the FDA but have no “Clinical Benefit”..,and further more they have 4 years that they do have CB..MC $6 billion and rising
Anp has a drug for DMD safe and Tolerable and shows Clinical Benefit (CB) Mc $35 mill
But not for long...$$$
ATL1102 Blockbuster drug in 2020 and a Coy maker., page-4
-
- There are more pages in this discussion • 180 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.015(13.0%) |
Mkt cap ! $117.2M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 13.5¢ | 12.0¢ | $612.7K | 4.843M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 56662 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 600000 | 2 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |